Clincosm LogoSign in Get a demo

MDS

Showing NaN - NaN of 19
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

AML, MDS Trial in Houston (Vibecotamab, Dexamethasone, Acetaminophen)

Recruiting
  • AML
  • MDS
  • Houston, Texas
    M D Anderson Cancer Center
Sep 29, 2022

Myelodysplastic Syndrome, MDS, Refractory Anemia With Excess Blasts Trial in Worldwide (rigosertib, Any approved or

Terminated
  • Myelodysplastic Syndrome
  • +3 more
  • La Jolla, California
  • +157 more
Sep 22, 2022

Hematologic Malignancy, AML, ALL Trial in Australia, United States (Tagraxofusp, Fludarabine, Cytarabine)

Not yet recruiting
  • Hematologic Malignancy
  • +10 more
  • Los Angeles, California
  • +28 more
Jul 26, 2022

MDS, MDS Trial in Tampa, Boston, Houston (APR-548 + Azacitidine)

Terminated
  • MDS
  • Myelodysplastic Syndromes
  • APR-548 + Azacitidine
  • Tampa, Florida
  • +3 more
Jul 20, 2022

Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Canada, United States (CFI-400945, Azacitidine,

Recruiting
  • Acute Myeloid Leukemia
  • +5 more
  • Duarte, California
  • +7 more
Jul 20, 2022

AML, Adult, MDS, Relapse/Recurrence Trial in United States (BST-236)

Recruiting
  • AML, Adult
  • +3 more
  • Shreveport, Louisiana
  • +3 more
Jul 19, 2022

AML, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in United States (APG-115, 5-azacitidine)

Recruiting
  • AML
  • +6 more
  • Gilbert, Arizona
  • +7 more
Jul 8, 2022

Relapsed/Refractory AML, AML, Adult, MDS Trial in United States (NKX101 - CAR NK cell therapy)

Recruiting
  • Relapsed/Refractory AML
  • +3 more
  • NKX101 - CAR NK cell therapy
  • Denver, Colorado
  • +6 more
Apr 8, 2022

AML, MDS Trial in United States (APVO436)

Recruiting
  • AML
  • MDS
  • APVO436
  • San Francisco, California
  • +11 more
Feb 8, 2022

MDS, CMML, AML Trial in Canada, United States (SGI-110)

Completed
  • MDS
  • +2 more
  • Scottsdale, Arizona
  • +15 more
Apr 16, 2021

Myelodysplastic Syndrome, MDS Trial in Canada, United States (ASTX727 Dose Escalation, ASTX727 Dose Confirmation, ASTX727

Completed
Has Results
  • Myelodysplastic Syndrome
  • MDS
  • ASTX727 Dose Escalation
  • +2 more
  • Phoenix, Arizona
  • +16 more
Dec 1, 2020

MDS, MDS, RAEB Trial in Worldwide (ON 01910.Na)

Completed
  • Myelodysplastic Syndromes
  • +3 more
  • ON 01910.Na
  • Scottsdale, Arizona
  • +86 more
Jun 29, 2020

Acute Myeloid Leukemia, Leukemia, Myelodysplastic Syndrome Trial in Georgia, United States (AC220)

Completed
Has Results
  • Acute Myeloid Leukemia
  • +4 more
  • Birmingham, Alabama
  • +4 more
Apr 23, 2020

Leukemia, AML, MDS Trial in Houston (Azacitidine)

Completed
Has Results
  • Leukemia
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 6, 2020

AML, MDS, CMML Trial in United States (E6201)

Terminated
Has Results
  • AML
  • +2 more
  • Denver, Colorado
  • +3 more
Mar 7, 2019

Myelodysplastic Syndrome, MDS Trial in United States (pracinostat, Azacitidine, Decitabine)

Completed
  • Myelodysplastic Syndrome
  • MDS
  • Mobile, Alabama
  • +20 more
Feb 22, 2017

AML, ALL, Blast Crisis Trial in United States (TG02 citrate, Carfilzomib, Dexamethasone)

Completed
  • AML
  • +4 more
  • TG02 citrate
  • +2 more
  • Denver, Colorado
  • +8 more
May 5, 2016

Leukemia, AML, MDS Trial in Houston (Cytarabine, Fludarabine)

Completed
Has Results
  • Leukemia
  • +3 more
  • Houston, Texas
    UT MD Anderson Cancer Center
Feb 17, 2016

MDS, MDS Trial in Houston (Gimatecan)

Completed
  • Myelodysplastic Syndromes
  • MDS
  • Houston, Texas
    The University of Texas M.D. Anderson Cancer Center
May 11, 2015